Stemtech Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 1.13 million compared to USD 1.16 million a year ago. Net loss was USD 2.24 million compared to USD 0.49474 million a year ago.

Basic loss per share from continuing operations was USD 0.04 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.04 compared to USD 0.01 a year ago.